Revenue
2022
2023
2024
2025
Coya Therapeutics, Inc. (COYA)
Price$4.61Cached quote
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $7.9M | $3.6M | $6.0M | $0 | — |
| Research & development | $16.7M | $11.9M | $5.5M | $4.4M | $2.5M |
| Operating expenses | $30.5M | $20.8M | $13.9M | $9.8M | $4.9M |
| Operating income | −$22.6M | −$17.2M | −$7.9M | −$9.8M | −$4.9M |
| Operating margin | −283.87% | −485.35% | −131.67% | — | — |
| EBITDA | −$22.5M | −$17.2M | −$7.9M | −$9.8M | −$4.9M |
| EBITDA margin | −283.52% | −484.58% | −131.22% | — | — |
| Net income | −$21.2M | −$14.9M | −$8.0M | −$12.2M | −$4.9M |
| Net profit margin | −267.14% | −418.70% | −133.08% | — | — |
| Basic EPSper basic share | -$1.27 | -$0.98 | -$0.79 | -$4.73 | -$1.89 |
| Diluted EPSper diluted share | -$1.27 | -$0.98 | -$0.79 | -$4.73 | -$1.89 |
Owners
Reported shareholders
9.96%of listed shares
DME Capital Management, LP2.34M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
DME Capital Management, LP | 9.96%2.34M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 3.59%842.22K shares |
Alyeska Investment Group, L.P. | 3.41%800K shares |
AIGH Capital Management LLC | 2.69%631.91K shares |
CM Management, LLC | 1.71%400K shares |
PRIVATE MANAGEMENT GROUP INC | 1.64%384.22K shares |
MARSHALL WACE, LLP | 1.06%249.79K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.97%228.24K shares |
RENAISSANCE TECHNOLOGIES LLC | 0.82%192.99K shares |
Prosight Management, LP | 0.72%170K shares |
DIMENSIONAL FUND ADVISORS LP | 0.66%155.92K shares |
VANGUARD FIDUCIARY TRUST CO | 0.55%129.55K shares |
JONES FINANCIAL COMPANIES LLLP | 0.47%110.91K shares |
BlackRock, Inc. | 0.44%102.41K shares |
PRELUDE CAPITAL MANAGEMENT, LLC | 0.43%101.33K shares |
JBF Capital, Inc. | 0.43%100.01K shares |
ROYAL BANK OF CANADA | 0.40%93.41K shares |
MORGAN STANLEY | 0.35%82.11K shares |
STATE STREET CORP | 0.34%79.81K shares |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.26%61.01K shares |
Percentages use 23.46M shares of this listed class outstanding on Jun 30, 2026.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Nov 14, 2024Form 4 | SNYDER DAVID SChief Financial Officer | BuyCommon Stock, par value $0.0001 per share | 1.8K | $7.19 | $12.9K | 8.8K |
| Nov 13, 2024Form 4 | Swaminathan ArunChief Executive Officer | BuyCommon Stock, par value $0.0001 per share | 5.0K | $7.36 | $36.8K | 10.0K |
| Nov 11, 2024Form 4 | Grossman FredChief Medical Officer | BuyCommon Stock, par value $0.0001 per share | 2.7K | $7.37 | $20.0K | 2.7K |
| Nov 11, 2024Form 4 | Swaminathan ArunChief Executive Officer | BuyCommon Stock, par value $0.0001 per share | 5.0K | $7.34 | $36.7K | 5.0K |